Literature DB >> 26002166

A uniform management approach to optimize outcome in fetal growth restriction.

Viola Seravalli1, Ahmet A Baschat2.   

Abstract

A uniform approach to the diagnosis and management of fetal growth restriction (FGR) consistently produces better outcome, prevention of unanticipated stillbirth, and appropriate timing of delivery. Early-onset and late-onset FGR represent two distinct clinical phenotypes of placental dysfunction. Management challenges in early-onset FGR revolve around prematurity and coexisting maternal hypertensive disease, whereas in late-onset disease failure of diagnosis or surveillance leading to unanticipated stillbirth is the primary issue. Identifying the surveillance tests that have the highest predictive accuracy for fetal acidemia and establishing the appropriate monitoring interval to detect fetal deterioration is a high priority.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biophysical profile score; Fetal Doppler; Fetal acidemia; Fetal growth restriction; Fetal testing; Middle cerebral artery; Neonatal outcome; Umbilical artery

Mesh:

Year:  2015        PMID: 26002166     DOI: 10.1016/j.ogc.2015.01.005

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  9 in total

1.  Stillbirths at Term: Case Control Study of Risk Factors, Growth Status and Placental Histology.

Authors:  Federico Mecacci; Caterina Serena; Laura Avagliano; Mauro Cozzolino; Eleonora Baroni; Marianna Pina Rambaldi; Serena Simeone; Francesca Castiglione; Gian Luigi Taddei; Gaetano Bulfamante
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

2.  Evaluation of the INTERGROWTH-21st project newborn standard for use in Canada.

Authors:  Shiliang Liu; Amy Metcalfe; Juan Andrés León; Reg Sauve; Michael S Kramer; K S Joseph
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

3.  Protocol for the prospective observational clinical study: estimation of fetal weight by MRI to PREdict neonatal MACROsomia (PREMACRO study) and small-for-gestational age neonates.

Authors:  Caroline Kadji; Mieke M Cannie; Andrew Carlin; Jacques C Jani
Journal:  BMJ Open       Date:  2019-03-27       Impact factor: 2.692

4.  Magnetic resonance imaging of skull and brain parameters in fetuses with intrauterine growth restriction.

Authors:  Ronaldo Eustáquio de Oliveira Júnior; Sara Reis Teixeira; Eduardo Félix Martins Santana; Jorge Elias Junior; Fabricio da Silva Costa; Edward Araujo Júnior; Alessandra Cristina Marcolin
Journal:  Radiol Bras       Date:  2021 May-Jun

5.  Fetal size classified using gestational days rather than gestational weeks improves correlation with stillbirth risk: A statewide population study.

Authors:  Natasha L Pritchard; Stephen Tong; Susan P Walker; Anthea C Lindquist
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

6.  Adjusting growth standards for fetal sex improves correlation of small babies with stillbirth and adverse perinatal outcomes: A state-wide population study.

Authors:  Natasha L Pritchard; Susan P Walker; Alexandra R Mitchell; Stephen Tong; Anthea C Lindquist
Journal:  PLoS One       Date:  2022-10-10       Impact factor: 3.752

Review 7.  A Novel Review of Homocysteine and Pregnancy Complications.

Authors:  Chuce Dai; Yiming Fei; Jianming Li; Yang Shi; Xiuhua Yang
Journal:  Biomed Res Int       Date:  2021-05-06       Impact factor: 3.411

8.  Fetal Hemodynamic Parameters in Low Risk Pregnancies: Doppler Velocimetry of Uterine, Umbilical, and Middle Cerebral Artery.

Authors:  C O Figueira; F G Surita; M S Dertkigil; S L Pereira; J R Bennini; S S Morais; J Mayrink; J G Cecatti
Journal:  ScientificWorldJournal       Date:  2016-11-13

9.  The impact of assisted reproductive technology on prenatally diagnosed fetal growth restriction in dichorionic twin pregnancies.

Authors:  Viola Seravalli; Lorenzo Maoloni; Lucia Pasquini; Sara Bolzonella; Giovanni Sisti; Felice Petraglia; Mariarosaria Di Tommaso
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.